基于反感性寡核酸和RNA干扰的内分泌疾病的致病基因治疗方法
Olga Golounina1, Ildar Minniakhmetov2, Ramil Salakhov2
1Department of Clinical Endocrinology, Endocrinology Research Centre, Moscow, Russia.
Frontiers in endocrinology
|February 13, 2025
概括
针对RNA的疗法,如反感性寡核酸 (ASOs) 和小干扰RNA (siRNAs),为内分泌疾病提供了新的治疗方法,包括糖尿病和肥胖症. 这些基于核酸的药物精确调节单基因和复杂疾病的基因表达,包括N-of-1方法.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 内分泌学 在内分泌学.
背景情况:
- 分子疗法,利用基于核酸的药物,为抗常规治疗的疾病提供了一个有希望的替代方案.
- 反感性寡核酸 (ASO) 和小干扰RNA (siRNA) 是精确基因表达调制的关键RNA向策略.
- 这些疗法为目标患者群体和个性化N-of-1治疗方法提供了潜力.
研究的目的:
- 审查针对内分泌疾病的RNA向治疗机会,重点关注糖尿病和肥胖.
- 探索ASOs和siRNAs在单基因,多基因和复杂内分泌疾病中的应用.
- 讨论基于反感的疗法的潜力,用于罕见和超罕见的内分泌疾病.
主要方法:
- 对当前反意义分子和RNA向治疗策略的文献综述.
- 分析ASOs和siRNAs在内分泌病原发生过程中调节基因表达的机制.
- 专注于糖尿病 (包括单一的形式) 和肥胖 (综合征和单一的形式) 的应用.
主要成果:
- 向RNA疗法有效调节内分泌疾病中的致病机制,例如胰岛素信号缺陷和荷尔蒙失衡.
- ASO和siRNA可以降低复杂内分泌疾病中的过度活跃途径,在分子层面解决它们.
- ASO的特定序列结合对于开发高精度的N-of-1疗法特别有利.
结论:
- 分子疗法在治疗广泛的内分泌疾病方面具有显著的前景,从单一的到复杂的形式.
- 基于反感的治疗方法为内分泌疾病管理提供了精确和适应性的方法,包括个性化医学.
- 进一步开发RNA向疗法可能会彻底改变罕见和超罕见内分泌疾病的治疗.
相关概念视频
siRNA - Small Interfering RNAs
16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Small interfering RNAs (siRNA)
3.5K
3.5K
Types of RNA
63.1K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.1K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


